Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T17:50:48.407Z.
Calculation as of: 2026-10-06T17:50:48.407Z.
Quote observation: 2026-10-06T17:50:03.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: ee881eee59918e8cff759d9372c22030baed04f147f6b571d3011c58a892a573
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
Market Cap
$90.73M
Free Cash Flow Yield
N/A
TTM Avg
23.21%
3Y Avg
23.21%
5Y Avg
23.21%
Market Cap
$90.32M
Free Cash Flow Yield
29.16%
TTM Avg
26.97%
3Y Avg
26.97%
5Y Avg
26.97%
Market Cap
$89.33M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$88.21M
Free Cash Flow Yield
4.78%
TTM Avg
2.62%
3Y Avg
2.45%
5Y Avg
2.45%
Market Cap
$93.01M
Free Cash Flow Yield
5342.51%
TTM Avg
1623.44%
3Y Avg
1623.44%
5Y Avg
1623.44%
Market Cap
$88.21M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$88.60M
Free Cash Flow Yield
24.46%
TTM Avg
19.27%
3Y Avg
25.95%
5Y Avg
22.72%
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Biomea Fusion, Inc. (BMEA) | $90.37M | N/A | N/A | N/A | N/A |
| Equillium, Inc. (EQ)vs › | $90.73M | N/A | 23.21% | 23.21% | 23.21% |
| Rallybio Corporation (RLYB)vs › | $90.32M | 29.16% | 26.97% | 26.97% | 26.97% |
| electroCore, Inc. (ECOR)vs › | $89.53M | N/A | N/A | N/A | N/A |
| PMV Pharmaceuticals, Inc. (PMVP)vs › | $89.33M | N/A | N/A | N/A | N/A |
| ImmuCell Corporation (ICCC)vs › | $88.21M | 4.78% | 2.62% | 2.45% | 2.45% |
| Park Dental Partners, Inc. Common Stock (PARK)vs › | $93.01M | 5342.51% | 1623.44% | 1623.44% | 1623.44% |
| Neumora Therapeutics, Inc. Common Stock (NMRA)vs › | $88.21M | N/A | N/A | N/A | N/A |
| CareCloud, Inc. (CCLD)vs › | $88.60M | 24.46% | 19.27% | 25.95% | 22.72% |
| Atara Biotherapeutics, Inc. (ATRA)vs › | $86.50M | N/A | N/A | N/A | N/A |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
